Wittlinger, Florian
Ogboo, Blessing C.
Shevchenko, Ekaterina http://orcid.org/0000-0002-2078-0740
Damghani, Tahereh
Pham, Calvin D.
Schaeffner, Ilse K.
Oligny, Brandon T. http://orcid.org/0009-0004-5730-5611
Chitnis, Surbhi P.
Beyett, Tyler S. http://orcid.org/0000-0001-5509-7004
Rasch, Alexander
Buckley, Brian
Urul, Daniel A.
Shaurova, Tatiana
May, Earl W.
Schaefer, Erik M.
Eck, Michael J. http://orcid.org/0000-0003-4247-9403
Hershberger, Pamela A.
Poso, Antti http://orcid.org/0000-0003-4196-4204
Laufer, Stefan A. http://orcid.org/0000-0001-6952-1486
Heppner, David E. http://orcid.org/0000-0002-0722-5160
Funding for this research was provided by:
Startup funds from The State University of New York
Article History
Received: 6 September 2023
Accepted: 16 January 2024
First Online: 20 February 2024
Competing interests
: D.E.H., F.W., B.C.O., C.D.P., A.R., and S.A.L. are inventors on a provisional patent (63/483,871 filed 2/8/2023) comprising aspects of the molecules in this study. D.E.H. has been a consultant to Addition L.P. and is a member of the advisory board for Tropocan Therapeutics. D.A.U., E.M.S., and E.W.M. are employees and shareholders of AssayQuant Technologies, Inc., a provider of life science tool products and services that support drug discovery, including the PhosphoSens platform used to generate the data presented here. M.J.E. is a consultant to Novartis, and the Eck laboratory receives or has received research funding from Novartis, Takeda, Sanofi, and Arbella. All other authors declare no competing interest.